- Home
- NFG vs LEGN Comparison
NFG vs LEGN Comparison
Compare NFG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFG | LEGN |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 5.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NFG | LEGN |
|---|---|---|
| Price | $81.96 | $21.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $91.20 | $69.58 |
| AVG Volume (30 Days) | 604.3K | ★ 2.4M |
| Earning Date | 01-28-2026 | 11-12-2025 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 576.19 | N/A |
| EPS | ★ 5.68 | N/A |
| Revenue | ★ $2,277,541,000.00 | $909,045,000.00 |
| Revenue This Year | $15.96 | $68.52 |
| Revenue Next Year | $24.46 | $48.63 |
| P/E Ratio | $14.45 | ★ N/A |
| Revenue Growth | 17.11 | ★ 74.75 |
| 52 Week Low | $60.48 | $21.19 |
| 52 Week High | $94.13 | $45.30 |
Technical Indicators
Market Signals| Indicator | NFG | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 30.32 |
| Support Level | $80.54 | $21.19 |
| Resistance Level | $81.63 | $23.24 |
| Average True Range (ATR) | 1.35 | 0.69 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 57.29 | 18.54 |
Price Performance
Historical ComparisonAbout NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.